|
Pharmacology
Citations 131-140 of 165 total displayed.
|
Past content
(since Dec 2002):
|
- CLINICAL
Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis
- B. Galarraga, M. Ho, H. M. Youssef, A. Hill, H. McMahon, C. Hall, S. Ogston, G. Nuki, and J. J. F. Belch
Rheumatology 2008; 47: 665-669.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Risk of cancer in Turkish patients after treatment with TNF antagonists
- S. Pay for The Society for Research and Education in Rheumatology of Turkey
Rheumatology 2008; 47: 548-549.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: The pharmacogenetics of methotrexate: reply
- S. Hider, I. Bruce, and W. Thomson
Rheumatology 2008; 47: 557-a--a558.
[Extract]
[Full Text]
- REVIEWS
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
- J. A. M. Wessels, T. W. J. Huizinga, and H.-J. Guchelaar
Rheumatology 2008; 47: 249-255.
[Abstract]
[Full Text]
- CLINICAL
New CIAS1 mutation and anakinra efficacy in overlapping of Muckle–Wells and familial cold autoinflammatory syndromes
- L. Maksimovic, J. Stirnemann, F. Caux, N. Ravet, S. Rouaghe, L. Cuisset, E. Letellier, G. Grateau, A.-S. Morin, and O. Fain
Rheumatology 2008; 47: 309-310.
[Abstract]
[Full Text]
- CLINICAL
Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus
- C. Gordon, D. J. Wallace, S. Shinada, K. C. Kalunian, L. Forbess, G. D. Braunstein, and M. H. Weisman
Rheumatology 2008; 47: 334-338.
[Abstract]
[Full Text]
- CLINICAL
Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis
- P. Tynjälä, K. Kotaniemi, P. Lindahl, K. Latva, K. Aalto, V. Honkanen, and P. Lahdenne
Rheumatology 2008; 47: 339-344.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Co-proxamol: where have all the patients gone?
- L. Ottewell and D. J. Walker
Rheumatology 2008; 47: 375.
[Extract]
[Full Text]
- CASE REPORTS
Three significant cases of neutropenia with etanercept
- C. Wenham, K. Gadsby, and C. Deighton
Rheumatology 2008; 47: 376-377.
[Extract]
[Full Text]
- EDITORIALS
Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance
- A. Wailoo, N. Bansback, and J. Chilcott
Rheumatology 2008; 47: 119-120.
[Extract]
[Full Text]
|
|
